A crossover study of allopurinol administration to a schizophrenic child.
D000284:Administration, Oral; D000493:Allopurinol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004035:Diet Therapy; D004305:Dose-Response Relationship, Drug; D004454:Echolalia / Q000188:drug therapy; D006801:Humans; D008297:Male; D010919:Placebos; D011687:Purines / Q000008:administration & dosage / Q000378:metabolism; D012075:Remission, Spontaneous; D012559:Schizophrenia / Q000235:genetics; D012561:Schizophrenia, Childhood / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D012649:Self Concept; D014527:Uric Acid / Q000096:biosynthesis / Q000097:blood / Q000652:urine; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D010919:Placebos; D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase